Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program.
Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program.
复制标题
DOI:
10.3390/vaccines10020188
复制
发表时间:
2022-01-25
期刊:
影响因子:
7.8
通讯作者:
For The Mint Study Group
中科院分区:
文献类型:
--
作者:
Onuki M;Yamamoto K;Yahata H;Kanao H;Horie K;Konnai K;Nio A;Takehara K;Kamiura S;Tsuda N;Takei Y;Shigeta S;Nakai H;Yoshida H;Motohara T;Kato T;Nakamura K;Hamanishi J;Tasaka N;Ishikawa M;Kado N;Taira Y;Mori M;Iwata T;Takahashi F;Kukimoto I;Yoshikawa H;Yaegashi N;Matsumoto K;For The Mint Study Group
Since the human papillomavirus (HPV) vaccination program for Japanese girls aged 12–16 years began in 2010, vaccination uptake has been low in women born before 1993 but high (approximately 70%) in those born during 1994–1999. We previously compared the prevalence of vaccine types HPV16 and HPV18 in cervical intraepithelial neoplasia grade 1–3 (CIN1–3) or adenocarcinoma in situ (AIS) between vaccinated and unvaccinated cohorts and found direct protection effects among vaccinated women in Japan. In this study, we focused on changes in HPV16/18 prevalence among “unvaccinated” cohorts with CIN/AIS. We analyzed HPV16/18 prevalence among 5051 unvaccinated women aged <40 years, newly diagnosed with CIN/AIS during 2012–2021 for time trends. Declining trends in HPV16/18 prevalence over 9 years were observed in CIN1 (36.0–10.0%, Ptrend = 0.03) and CIN2–3/AIS (62.5–36.4%, Ptrend = 0.07) among women aged <25 years. HPV16/18 prevalence in CIN1 and CIN2–3/AIS diagnosed at age 20–24 years was lower in 1994–1999 birth cohorts compared with 1988–1993 birth cohorts (4.5% vs. 25.7% for CIN1 and 40.0% vs. 58.1% for CIN2–3/AIS, both p = 0.04). Significant reduction in HPV16/18 prevalence among young unvaccinated women with CIN1 and CIN2–3/AIS suggests herd effects of HPV vaccination in Japan.
登录
查看更多内容
DOI:
10.1093/cid/ciaa1770
发表时间:
2021-03-01
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
Hoes J;Woestenberg PJ;Bogaards JA;King AJ;de Melker HE;Berkhof J;Hoebe CJPA;van der Sande MAB;van Benthem BHB;Medical Microbiological Laboratories and Public Health Services
通讯作者:
Medical Microbiological Laboratories and Public Health Services
影响因子:
1.6
作者:
Tanaka, Hidenori;Shirasawa, Hiromitsu;Terada, Yukihiro
通讯作者:
Terada, Yukihiro
DOI:
10.1093/infdis/jix244
发表时间:
2017-09-01
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
Oliver SE;Unger ER;Lewis R;McDaniel D;Gargano JW;Steinau M;Markowitz LE
通讯作者:
Markowitz LE
影响因子:
5.7
作者:
Yagi A;Ueda Y;Nakagawa S;Masuda T;Miyatake T;Ikeda S;Abe H;Hirai K;Sekine M;Miyagi E;Enomoto T;Nakayama T;Kimura T
通讯作者:
Kimura T
影响因子:
6.4
作者:
Kudo, Risa;Yamaguchi, Manako;Enomoto, Takayuki
通讯作者:
Enomoto, Takayuki